202 related articles for article (PubMed ID: 16882104)
21. Lafutidine facilitates calcitonin gene-related peptide (CGRP) nerve-mediated vasodilation via vanilloid-1 receptors in rat mesenteric resistance arteries.
Sugiyama T; Hatanaka Y; Iwatani Y; Jin X; Kawasaki H
J Pharmacol Sci; 2008 Mar; 106(3):505-11. PubMed ID: 18344609
[TBL] [Abstract][Full Text] [Related]
22. The effects of 15 days of dosing with placebo, sufotidine 600 mg nocte or sufotidine 600 mg twice daily upon 24-hour intragastric acidity and 24-hour plasma gastrin.
Rogers MJ; Holmfield JH; Primrose JN; Johnston D
Aliment Pharmacol Ther; 1990; 4 Suppl 1():65-74. PubMed ID: 1983347
[TBL] [Abstract][Full Text] [Related]
23. Cetraxate raises levels of calcitonin gene-related peptide and substance P in human plasma.
Katagiri F; Sato Y; Itoh H; Takeyama M
J Pharm Pharmacol; 2004 Apr; 56(4):557-61. PubMed ID: 15099451
[TBL] [Abstract][Full Text] [Related]
24. Gastroretentive mucoadhesive tablet of lafutidine for controlled release and enhanced bioavailability.
Patil S; Talele GS
Drug Deliv; 2015 May; 22(3):312-9. PubMed ID: 24471787
[TBL] [Abstract][Full Text] [Related]
25. Clinical application of an enzyme immunoassay for cholecystokinin-like immunoreactive substance for determination of the human plasma levels: the effect of metoclopramide on gastrointestinal peptides and stress-related hormones.
Katagiri F; Inoue S; Itoh H; Takeyama M
J Pept Sci; 2006 May; 12(5):311-20. PubMed ID: 16245263
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics, pharmacodynamics, and tolerability of the dipeptidyl peptidase IV inhibitor LC15-0444 in healthy Korean men: a dose-block-randomized, double-blind, placebo-controlled, ascending single-dose, Phase I study.
Lim KS; Kim JR; Choi YJ; Shin KH; Kim KP; Hong JH; Cho JY; Shin HS; Yu KS; Shin SG; Kwon OH; Hwang DM; Kim JA; Jang IJ
Clin Ther; 2008 Oct; 30(10):1817-30. PubMed ID: 19014837
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.
Smith WB; Dowell JA; Pratt RD
Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688
[TBL] [Abstract][Full Text] [Related]
28. Prophylactic effect of lafutidine against the adverse reaction induced in rat stomach by repeated administration of 5-fluorouracil.
Kotani T; Nakagiri A; Murashima Y; Takeuchi K
Inflammopharmacology; 2007 Oct; 15(5):203-8. PubMed ID: 17943252
[TBL] [Abstract][Full Text] [Related]
29. Afferent signalling from the acid-challenged rat stomach is inhibited and gastric acid elimination is enhanced by lafutidine.
Edelsbrunner ME; Nakano M; Holzer P
BMC Gastroenterol; 2009 Jun; 9():40. PubMed ID: 19490646
[TBL] [Abstract][Full Text] [Related]
30. Characterization of metabolites of a novel histamine H(2)-receptor antagonist, lafutidine, in human liver microsomes by liquid chromatography coupled with ion trap mass spectrometry.
Wang Y; Chen X; Li Q; Zhong D
Rapid Commun Mass Spectrom; 2008 Jun; 22(12):1843-52. PubMed ID: 18470870
[TBL] [Abstract][Full Text] [Related]
31. Calcitonin gene-related peptide levels are elevated in patients with sepsis.
Joyce CD; Fiscus RR; Wang X; Dries DJ; Morris RC; Prinz RA
Surgery; 1990 Dec; 108(6):1097-101. PubMed ID: 2247835
[TBL] [Abstract][Full Text] [Related]
32. Dose-response effect of a beta3-adrenergic receptor agonist, solabegron, on gastrointestinal transit, bowel function, and somatostatin levels in health.
Grudell AB; Camilleri M; Jensen KL; Foxx-Orenstein AE; Burton DD; Ryks MD; Baxter KL; Cox DS; Dukes GE; Kelleher DL; Zinsmeister AR
Am J Physiol Gastrointest Liver Physiol; 2008 May; 294(5):G1114-9. PubMed ID: 18372395
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetic Properties of Oral Lafutidine Tablets and the Effect of Food on its Pharmacokinetics in Healthy Chinese Subjects.
Li S; Xu M; Li H; Du J; Li W
Adv Ther; 2016 Oct; 33(10):1704-1714. PubMed ID: 27444313
[TBL] [Abstract][Full Text] [Related]
34. Potent and long-lasting action of lafutidine on the human histamine H(2) receptor.
Fukushima Y; Otsuka H; Ishikawa M; Asano T; Anai M; Katsube T; Ogawa K; Kajiwara T; Ohkawa S; Ishikawa T; Omata M; Saitoh T
Digestion; 2001; 64(3):155-60. PubMed ID: 11786663
[TBL] [Abstract][Full Text] [Related]
35. Hypotension- and endotoxin-induced alterations in calcitonin gene-related peptide: modulation by dexamethasone.
Wang X; Han CD; Fiscus RR; Qi M; Jones SB
Circ Shock; 1991 Jun; 34(2):217-23. PubMed ID: 1934321
[TBL] [Abstract][Full Text] [Related]
36. Early effects of oral administration of lafutidine with mosapride compared with lafutidine alone on intragastric pH values.
Iida H; Inamori M; Nozaki Y; Endo H; Hosono K; Akiyama T; Sakamoto Y; Takahashi H; Koide T; Tokoro C; Abe Y; Nakajima A
BMC Gastroenterol; 2009 Jul; 9():52. PubMed ID: 19589146
[TBL] [Abstract][Full Text] [Related]
37. Comparative study of plasma gastrin levels in rats after two months of ebrotidine administration.
Romero A; Gómez F; Villamayor F; Ballesta A; Sacristán A; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):524-7. PubMed ID: 9205757
[TBL] [Abstract][Full Text] [Related]
38. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers.
Alkhalidi BA; Tamimi JJ; Salem II; Ibrahim H; Sallam AA
Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838
[TBL] [Abstract][Full Text] [Related]
39. Cardiopulmonary bypass influences the plasma levels of calcitonin gene-related peptides in dogs: effects of hemofiltration and hemodilution.
Isaka M; Imamura M; Sakuma I; Makino Y; Shiiya N; Yasuda K
Res Vet Sci; 2007 Feb; 82(1):110-4. PubMed ID: 16839577
[TBL] [Abstract][Full Text] [Related]
40. Dual effect of lafutidine on the gut and liver.
Kaneko H
J Gastroenterol Hepatol; 2003 Mar; 18(3):237-8. PubMed ID: 12603521
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
